Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06665321

Internet-based Affect Focused Psychodynamic Therapy for Neuroticism: a Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
108 (estimated)
Sponsor
Linkoeping University · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to investigate if internet delivered affect-focused psychodynamic therapy (IPDT) leads to lowered levels of trait neuroticism compared to a wait-list control condition. The target group is adults (18+) who experience mild to moderate symptoms of anxiety and/or depression. The IPDT treatment consists of 8 modules that the participants will work with for 9 weeks, with therapist support. Participants will be recruited in Sweden with nationwide recruitment.

Detailed description

This study is a randomized controlled trial with the aim to investigate if IPDT leads to lowered levels of trait neuroticism. Participants will either be randomized to the treatment which is based on Affect Phobia Therapy or to a wait-list control. Participants will have weekly contact with a therapist who will provide feedback and support. Primary outcome measure is trait neuroticism (measured on the 24-Item Neuroticism scale of the IPIP-NEO-120). Secondary outcome measures will include measures of anxiety, depression, quality of life, emotion regulation, and defense mechanism adaptiveness. Emotion regulation and short measure of anxiety and depressive symptoms will be collected weekly throughout the treatment period. Pre-treatment measurement, post-treatment measurement, weekly measure, and one-year follow up is planned to be collected through an online survey.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInternet-based psychodynamic therapy (IPDT)The intervention is 9 week long with weekly modules that the participants work with while receiving weekly support from an assigned therapist.

Timeline

Start date
2025-01-01
Primary completion
2025-04-01
Completion
2025-06-01
First posted
2024-10-30
Last updated
2024-11-12

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06665321. Inclusion in this directory is not an endorsement.